Capstone Investment Advisors
ONCE

Capstone Investment Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

Capstone Investment Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-53,374
Closed -$5.18M – 1491
2019
Q3 		$5.18M Buy
53,374
+2,583
+5% +$259K 0.04% 427
2019
Q2 		$5.2M Buy
50,791
+31,559
+164% +$3.41M 0.04% 443
2019
Q1 		$2.19M Buy
+19,232
New +$1.41M 0.02% 572

Capstone Investment Advisors's ONCE Position: Q4 2019 in Review

Capstone Investment Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 53,374 shares — an estimated $5.18M sold.

Capstone Investment Advisors first reported a position in ONCE in Q1 2019 and held it in 3 quarters. The position peaked at $5.2M in Q2 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

  • Capstone Investment Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Capstone Investment Advisors sold 53,374 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $5.18M.
  • Capstone Investment Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Capstone Investment Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $5.2M in Q2 2019.
  • 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Capstone Investment Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.